By repeatedly scanning the brains of a small group of patients for a year and a half, Weill Cornell Medicine researchers have identified a distinct pattern of neuronal interactions that appears to predispose some people to developing depression.

Awards, honors and achievements for the month of March.

Dr. Conor Liston, professor of psychiatry and of neuroscience in the Department of Psychiatry and the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, received the 2023 Thomas William Salmon Medal in Psychiatry from The New York Academy of Medicine.

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care May 17-18 during Weill Cornell Medicine’s commencement activities.

People with autism spectrum disorder can be classified into four distinct subtypes based on their brain activity and behavior.

A gene linked to autism spectrum disorders plays a critical role in early brain development and may shape the formation of both normal and atypical nerve connections in the brain.

New study by The Rockefeller University and Weill Cornell Medicine investigators illuminates the distributed nature of memory processing in the brain, and provides new insights into the process of memory recall, which is less understood than memory storage.

A three-year contract from Wellcome Leap will allow a team of investigators from Weill Cornell Medicine, Stanford Medicine and UC San Diego School of Medicine to study new ways to combat depression and create models that can predict which treatment is likely to work for individual patients.

Depression is the most common mental illness as well as the number one cause of disability among people between the ages of 15 and 44. And for millions of sufferers, antidepressants have literally saved lives that could otherwise have been lost to suicide.

To enable animals to shift their attention in response to changing circumstances, the prefrontal cortex of the brain helps keep track of which types of stimuli have recently been most relevant, suggests a preclinical study by Weill Cornell Medicine and NewYork-Presbyterian investigators

Decreased amounts of a neurotransmitter called GABA, whose main function is to reduce activity in the brain, leads to changes in the number of neurons in the developing brain and alters signaling between them.

New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.

The powerful but temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a new study.